VI Partners related stories
All articles and analysis
peHUB Wire: Tuesday, March 30, 2010Random Ramblings
- Activaero Raises €10.7 Million
Activaero GmbH, a German developer of controlled breathing devices for inhaled therapeutic agents, has raised €10.7 million in Series A funding. BioMedPartners led the round, and was joined by VI Partners, Abalis Finance AG and Vesalius Biocapital. MedVenture Partners served as placement agent.
- peHUB Wire: Thursday, October 29, 2009
Random Ramblings
- peHUB Wire: Thursday, October 29, 2009
Random Ramblings
- Exit watch, week of Sept. 21, 2009
News briefs about Evalve and other VC-backed companies bought in the past week
- peHUB Wire: Monday, September 14, 2009
Random Ramblings
- peHUB Wire: Monday, September 14, 2009
Random Ramblings
- Alcon Buying EsbaTech for Up To $589 Million
Alcon (NYSE:ACL) has agreed to acquire EsbaTech AG, a Swiss developer of antibody fragment therapeutics. The deal includes a $150 million up-front cash payment and up to $439 million in milestone payments. EsbaTech has raised around $86 million in VC funding, from firms like SV Life Sciences, Clarus Ventures, HBM BioVentures, HBM BioCapital, Novartis Bioventures, BioMedinvest and VI Partners.
- Endosense Raises $36 Million
Endosense, a Geneva, Switzerland-based med-tech company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has raised $36 million in Series B funding. Edmond de Rothschild Investment Partners led the round, and was joined by Neomed, GIMV, VI Partners, Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.
- peHUB Wire: Tuesday, September 1, 2009
Random Ramblings